Everest Medicines has dosed the first subject with EVM16, the company’s personalised mRNA cancer vaccine, in the EVM16CX01 ...

Persica's antibiotic-based drug could benefit patients with chronic lower back pain who are suffering from an infection in ...

Tris Pharma previously announced data from another Phase III trial of cebranopadol, which also met its primary endpoint.

The US FDA has ordered BioNTech to immediately halt its Phase I/II trial of BNT165e, a malaria vaccine candidate, pending ...

Biohaven’s pipeline drug BHV-7000 has failed to meet the primary endpoint in a pivotal Phase II/III bipolar trial.

NeOnc claims that its novel intranasal delivery platform will be able to bypass the blood-brain barrier and better target ...

Amgen and AstraZeneca have reported outcomes from the WAYPOINT trial of Tezspire for treating chronic rhinosinusitis with ...

The Phase I trial will recruit approximately 98 healthy volunteers and adults living with atopic dermatitis at a single site ...

In an anonymous post in the BMJ, the author claims that words relating to DEI could lead to grants being taken away.

The Phase II trial comes as the US Food and Drug Administration grants an investigational new drug application for cannabis ...

Trevi Therapeutics has finished enrolling subjects in a trial of investigational Haduvio for treating chronic cough in IPF ...

The CoTikiS trial’s 10-week results from the 50-week ulcerative colitis trial saw as an endoscopic improvement rate of 32% in ...